Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:28 AM
Ignite Modification Date:
2025-12-25 @ 1:28 AM
NCT ID:
NCT00660894
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed adenocarcinoma of colon
* Stage III (T1-4, N1-3, M0) disease
* Has undergone surgical resection of the tumor within the past 8 weeks
PATIENT CHARACTERISTICS:
* ECOG performance status 0-1
* Able to take medications orally
* WBC ≥ 3,500/mm³ and \< 12,000/mm³
* ANC ≥ 1,500/mm³
* Platelet count ≥ 100,000/mm³
* Hemoglobin ≥ 9.0 g/dL
* Total bilirubin ≤ 2.0 mg/dL
* AST/ALT ≤ 100 IU/L
* Creatinine ≤ 1.2 mg/dL
* No other active malignancies
* Must have none of the following comorbidities:
* Severe postoperative complications
* Uncontrollable diabetes mellitus
* Uncontrollable hypertension
* Myocardial infraction within 6 months
* Unstable angina pectoris
* Hepatocirrhosis
* Interstitial pneumonia, pulmonary fibrosis, or severe emphysema
PRIOR CONCURRENT THERAPY:
* No prior chemotherapy or radiotherapy for colon cancer
* No concurrent radiotherapy
* No concurrent biological response modifiers
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT00660894
Study Brief:
Protocol Section:
NCT00660894